fig2

Progress in the treatment of NK-cell lymphoma/leukemia

Figure 2. The scheme of molecular pathways and promising treatments for ENKL patients. LMP: Latent membrane protein; EBV: Epstein-Barr virus; HDAC: histone deacetylase.

Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/